For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associa ...

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is ...

The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...

LOS ANGELES, CA / ACCESSWIRE / January 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" ...

Creador is banking on MG’s low-cost platform to shake up key markets like North Asia and Europe. The challenge? Scaling globally while keeping MG’s lean and efficient DNA intact. Creador has ...